As part of our week of premier programming during the BIO International Convention in Boston, we’re bringing together industry leaders, investors, and strategic advisors for an engaging session on how European biotechs can successfully expand into the US market.
This dynamic lunchtime event will dive into unlocking US capital, driving strategic growth, and navigating the critical legal, business, and partnering pathways that fuel transatlantic success. Hear firsthand lessons from seasoned dealmakers and biotech executives in our expert panels and fireside chat and seize the opportunity to connect with key players shaping the future of global life sciences. This event is in partnership with Danforth Advisors.
Please RSVP here and see below for more details!
Date & Time: Tuesday, June 17 from 11:30 AM – 1:30 PM ET
Location: Goodwin’s Boston Office, 100 Northern Avenue, Boston, MA 02210
11:30 AM – 12:00 PM | Registration and Lunch
12:00 PM – 12:45 PM | Panel: Unlocking US Capital: Legal and Business Pathways – The Mindset for European Biotechs
- Gregg Beloff, Co-Founder and Managing Director, Danforth Advisors
- Robert Puopolo, Partner, Goodwin
- Henry Capper, Managing Director, Head of EMEA BioPharma, J.P. Morgan
12:50 PM – 1:30 PM | Fireside Chat: Partnering and M&A for European Biotechs: Lessons from the Zealand/Roche Experience
- Tim Worden, Partner, Goodwin
- Eric Cox, Chief Commercial Officer, Zealand Pharma